Competence-feedback and Therapy Outcome

January 26, 2021 updated by: Florian Weck, Johannes Gutenberg University Mainz

The Importance of Competence-feedback for Therapy Outcome: a Randomized Controlled Trial

In a randomized controlled study design, n = 58 treatments of patients with depression were to be conducted under a feedback-condition, in which the therapist would receive feedback five times within 20 treatment sessions. The competence-feedback includes detailed feedback about 14 different aspects of therapist behavior. The control group includes n = 58 further treatments within which therapists do not receive any competence-feedback (treatment as usual; TAU).

Study Overview

Status

Completed

Conditions

Detailed Description

Psychotherapeutic competencies are considered to be an important factor for therapy success. However, empirical studies which have investigated the competence-outcome relationship were only based on correlational analyses. Therefore, these studies are inappropriate for the investigation of causal relationships. In previous studies, feedback on therapists' competencies was found to be suitable for enhancing such competencies. Therefore, in the current research project, competence-feedback should be used to enhance therapeutic competencies systematically, in order to investigate the causal impact of these competencies on therapy outcome. Using a randomized controlled study design, n = 58 treatments of patients with depression were to be conducted under a feedback-condition, in which the therapist would receive feedback five times within 20 treatment sessions. The competence-feedback includes detailed feedback about 14 different aspects of therapist behavior. The control group includes n = 58 further treatments within which therapists do not receive any competence-feedback (treatment as usual; TAU). In order to ensure comparability of both treatment conditions (regarding an observation situation), the therapists in the TAU condition should also receive feedback, but only after the treatments are finished. We hypothesize that the feedback-group is superior to the TAU-group and that their treatments lead to significantly better therapy outcome. Moreover, we use mediator analysis to analyze whether the group-outcome relationship is mediated by therapeutic competencies or by the quality of the therapeutic alliance. The results are highly relevant for clinical process research, psychotherapy training and for the dissemination of treatment approaches in routine care.

Study Type

Interventional

Enrollment (Actual)

114

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Mainz, Germany, 55122
        • Johannes Gutenberg University

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

THERAPISTS

Inclusion Criteria:

  • Having successfully completed the interim Audit
  • Having started to treat ambulant patients

Exclusion Criteria:

---

PATIENTS

Inclusion Criteria:

  • Clinical diagnosis of Major Depression (Meeting DSM-IV criteria)
  • Informed consent

Exclusion Criteria:

  • Suicidal tendency
  • Clinical diagnosis of alcohol or drug addiction, acute schizophrenia, schizoaffective disorder or bipolar disorder
  • Clinical diagnosis of personality disorder cluster A (odd disorders) and B (dramatic, emotional or erratic)

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: competence-feedback
Therapists assigned to this group will receive standardized feedback on their psychotherapeutic competency after every fourth treatment session with a patient for a period of 20 therapy sessions. The feedback will be given by two experienced raters who are licensed as psychological psychotherapists.
competence-feedback
Placebo Comparator: control
Therapists assigned to this group will receive no competence-feedback.
control group without competence-feedback

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Beck Depression Inventory II (BDI II)
Time Frame: participants will be followed for the duration of psychotherapy, an expected average of 20 weeks
self-report measure to assess depressive symptoms
participants will be followed for the duration of psychotherapy, an expected average of 20 weeks

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Client Satisfaction Questionaire (CSQ8)
Time Frame: participants will be followed for the duration of psychotherapy, an expected average of 20 weeks
self-report measure to assess satisfaction with therapy
participants will be followed for the duration of psychotherapy, an expected average of 20 weeks
Health-related quality of life (SF-12)
Time Frame: participants will be followed for the duration of psychotherapy, an expected average of 20 weeks
self-report measure to assess health-related quality of life
participants will be followed for the duration of psychotherapy, an expected average of 20 weeks
Hamilton Depression Scale (HAMD-17)
Time Frame: participants will be followed for the duration of psychotherapy, an expected average of 20 weeks
external assessment to assess depressive symptoms
participants will be followed for the duration of psychotherapy, an expected average of 20 weeks
Inventory of Interpersonal Problems (IIP-C)
Time Frame: participants will be followed for the duration of psychotherapy, an expected average of 20 weeks
self-report instrument to identify a person's salient interpersonal difficulties based on the interpersonal circumplex model
participants will be followed for the duration of psychotherapy, an expected average of 20 weeks
Cognitive Therapy Scale (CTS)
Time Frame: participants will be followed for the duration of psychotherapy, an expected average of 20 weeks
external-assessment measure that assesses psychotherapeutic competency during a cognitive therapy session. CTS will be used by two trained raters licensed as psychological psychotherapists
participants will be followed for the duration of psychotherapy, an expected average of 20 weeks
Helping Alliance Questionaire (HAQ)
Time Frame: participants will be followed for the duration of psychotherapy, an expected average of 20 weeks
self-report measure to assess therapeutic alliance from the therapists perspective (therapist version; HAQ-T), the patients perspective (HAQ-P) and the raters perspective (HAQ-R)
participants will be followed for the duration of psychotherapy, an expected average of 20 weeks
Assessment of Patient Interpersonal Behavior (AFPIB)
Time Frame: participants will be followed for the duration of psychotherapy, an expected average of 20 weeks
assessment of patient in-session interpersonal behavior
participants will be followed for the duration of psychotherapy, an expected average of 20 weeks

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Collaborators

Investigators

  • Study Director: Florian Weck, PhD, University of Potsdam

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

August 1, 2015

Primary Completion (Actual)

September 1, 2020

Study Completion (Actual)

September 1, 2020

Study Registration Dates

First Submitted

June 19, 2015

First Submitted That Met QC Criteria

June 23, 2015

First Posted (Estimate)

June 24, 2015

Study Record Updates

Last Update Posted (Actual)

January 27, 2021

Last Update Submitted That Met QC Criteria

January 26, 2021

Last Verified

January 1, 2021

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • WE_01
  • WE 4652/7-1 (Other Grant/Funding Number: German Research foundation)

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Depression

Clinical Trials on competence-feedback

Subscribe